Free Trial
→ China’s message to Trump (From Porter & Company) (Ad)tc pixel Free RNAC Stock Alerts

Cartesian Therapeutics (RNAC) SEC Filings & 10K Form

Cartesian Therapeutics logo
$9.81 -0.23 (-2.29%)
Closing price 09/23/2025 04:00 PM Eastern
Extended Trading
$9.80 -0.01 (-0.05%)
As of 09/23/2025 04:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Cartesian Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/07/2025
6:05 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
6:08 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/16/2025
6:06 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025
6:02 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:04 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:05 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:13 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/29/2025
7:01 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
3:41 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form DEFA14A
04/25/2025
1:57 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SCHEDULE 13G
04/16/2025
3:35 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
English Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:29 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
6:04 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
6:50 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
6:04 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
6:06 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
5:59 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
8:28 AM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
01/27/2025
6:04 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:25 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
Form SCHEDULE 13D/A
01/15/2025
3:08 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
11:15 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
01/13/2025
11:15 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
01/13/2025
3:09 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:04 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2025
11:15 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
01/09/2025
11:15 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
01/09/2025
11:15 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
01/10/2025
5:00 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form POS AM
01/10/2025
5:01 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form POS AM
01/08/2025
3:33 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 424B7
01/08/2025
3:38 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 424B7
01/08/2025
3:30 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 424B3
01/07/2025
7:04 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Davis Blaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:04 PM		Brunn Carsten (Reporting)
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:05 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
English Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:05 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:05 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Miljkovic Milos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:05 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:21 PM		Brunn Carsten (Reporting)
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:14 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Singer Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:11 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
English Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
7:22 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
Form SCHEDULE 13D/A
12/23/2024
4:20 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:16 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/11/2024
3:28 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:21 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
3:36 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
5:03 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
5:50 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
5:51 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Singer Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
5:52 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:45 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
8:44 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
Form SC 13D/A
11/18/2024
6:28 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Miljkovic Milos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
6:32 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
6:35 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
6:23 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:24 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
4:07 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
6:31 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/07/2024
6:06 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:19 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
3:53 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kalayoglu Murat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:30 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kalayoglu Murat (Filed by)
Form SC 13D/A
10/15/2024
3:43 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Hoge Elizabeth (Reporting)
Seven One Eight Three Four Irrevocable Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
5:08 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
Form SC 13D/A
10/04/2024
4:58 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
11:15 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
10/01/2024
3:36 PM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 424B7
09/27/2024
3:13 PM		Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
3:20 PM		Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
Form SC 13D/A
09/26/2024
6:02 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
6:03 AM		Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RNAC) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners
Warren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the Nasdaq
New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...
Altimetry | Sponsoredtc pixel
Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...
SmartAsset | Sponsoredtc pixel
What The Silver Boom Could Mean For You…
AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...
Goldco Precious Metals | Sponsoredtc pixel
Claim Your Share of $5.39 BILLION in AI Equity Checks
The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...
Angel Publishing | Sponsoredtc pixel
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Trump’s new nightmare begins
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
Is This Nvidia’s Next Big Invention? (Picture Inside)
Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic proc...
InvestorPlace | Sponsoredtc pixel
Another gold high? Here’s the move Wall Street is missing …
Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...
Weiss Ratings | Sponsoredtc pixel